92 related articles for article (PubMed ID: 34087331)
21. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism.
Song WP; Zheng S; Yao HJ; Zhou XF; Li R; Zhang CY; Zhao JY; Wang LW; Shao RG; Li L
BMC Ophthalmol; 2020 Mar; 20(1):92. PubMed ID: 32143590
[TBL] [Abstract][Full Text] [Related]
22. Reduced Lipocalin 2 Expression Contributes to Vincristine Resistance in Human Colon Cancer Cells.
Guo X; Li Q; Wang YF; Wang TY; Chen SJ; Tian ZW
Recent Pat Anticancer Drug Discov; 2018; 13(2):248-254. PubMed ID: 29268690
[TBL] [Abstract][Full Text] [Related]
23. Effect of ligand troglitazone on peroxisome proliferator-activated receptor gamma expression and cellular growth in human colon cancer cells.
Ming M; Yu JP; Meng XZ; Zhou YH; Yu HG; Luo HS
World J Gastroenterol; 2006 Dec; 12(45):7263-70. PubMed ID: 17143939
[TBL] [Abstract][Full Text] [Related]
24. Induction of apoptosis and suppression of ERCC1 expression by the potent amonafide analogue 8-c in human colorectal carcinoma cells.
Wang Z; Liang X; Cheng Z; Xu Y; Yin P; Zhu H; Li Q; Qian X; Liu J
Anticancer Drugs; 2013 Apr; 24(4):355-65. PubMed ID: 23426174
[TBL] [Abstract][Full Text] [Related]
25. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
Takeda M; Mizokami A; Mamiya K; Li YQ; Zhang J; Keller ET; Namiki M
Prostate; 2007 Jun; 67(9):955-67. PubMed ID: 17440963
[TBL] [Abstract][Full Text] [Related]
26. NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer.
Huang TY; Chang TC; Chin YT; Pan YS; Chang WJ; Liu FC; Hastuti ED; Chiu SJ; Wang SH; Changou CA; Li ZL; Chen YR; Chu HR; Shih YJ; Cheng RH; Wu A; Lin HY; Wang K; Whang-Peng J; Mousa SA; Davis PJ
Cells; 2020 Aug; 9(8):. PubMed ID: 32756527
[TBL] [Abstract][Full Text] [Related]
27. Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38.
Gongora C; Candeil L; Vezzio N; Copois V; Denis V; Breil C; Molina F; Fraslon C; Conseiller E; Pau B; Martineau P; Del Rio M
Cancer Biol Ther; 2008 Jun; 7(6):822-32. PubMed ID: 18340113
[TBL] [Abstract][Full Text] [Related]
28. Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells.
Banerjee A; Banerjee V; Czinn S; Blanchard T
Oncotarget; 2017 Apr; 8(16):26142-26153. PubMed ID: 28412728
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.
Boyer J; Allen WL; McLean EG; Wilson PM; McCulla A; Moore S; Longley DB; Caldas C; Johnston PG
Cancer Res; 2006 Mar; 66(5):2765-77. PubMed ID: 16510598
[TBL] [Abstract][Full Text] [Related]
30. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
31. Synergistic potential of dual andrographolide and melatonin targeting of metastatic colon cancer cells: Using the Chou-Talalay combination index method.
Banerjee V; Sharda N; Huse J; Singh D; Sokolov D; Czinn SJ; Blanchard TG; Banerjee A
Eur J Pharmacol; 2021 Apr; 897():173919. PubMed ID: 33577837
[TBL] [Abstract][Full Text] [Related]
32. Silencing the wild-type and mutant K-ras increases the resistance to 5-flurouracil in HCT-116 as a colorectal cancer cell line.
Teimoori-Toolabi L; Hashemi S; Azadmanesh K; Eghbalpour F; Safavifar F; Khorramizadeh MR
Anticancer Drugs; 2015 Feb; 26(2):187-96. PubMed ID: 25325304
[TBL] [Abstract][Full Text] [Related]
33. Demonstration of differential gene expression between sensitive and resistant ovarian tumor cells by fluorescence differential display-PCR analysis.
Li L; Luan Y; Li X; Tang B; Zhang W; Li D; Zhao J; Wang G; Ding H; Reed E; Li QQ
Oncol Rep; 2005 May; 13(5):793-9. PubMed ID: 15809740
[TBL] [Abstract][Full Text] [Related]
34. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
[TBL] [Abstract][Full Text] [Related]
35. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
37. Cathepsin B mediated scramblase activation triggers cytotoxicity and cell cycle arrest by andrographolide to overcome cellular resistance in cisplatin resistant human hepatocellular carcinoma HepG2 cells.
Chowdhury KD; Sarkar A; Chatterjee S; Patra D; Sengupta D; Banerjee S; Chakraborty P; Sadhukhan GC
Environ Toxicol Pharmacol; 2019 May; 68():120-132. PubMed ID: 30889542
[TBL] [Abstract][Full Text] [Related]
38. Antiproliferative and apoptotic activities of 8-prenylnaringenin against human colon cancer cells.
Koosha S; Mohamed Z; Sinniah A; Ibrahim ZA; Seyedan A; Alshawsh MA
Life Sci; 2019 Sep; 232():116633. PubMed ID: 31278947
[TBL] [Abstract][Full Text] [Related]
39. In vivo passage of human prostate cancer cells in mice results in stable gene expression changes affecting numerous cancer-associated biological processes.
Sivanathan L; Chow A; Wong A; Hoang VC; Emmenegger U
Prostate; 2014 May; 74(5):537-46. PubMed ID: 24435653
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.
Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
Oncol Rep; 2016 Dec; 36(6):3682-3690. PubMed ID: 27779719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
